ReviewDigestive diseases and sciences2026
The Potential of Complementary and Alternative Therapies in Improving Diarrhea-Predominant Irritable Bowel Syndrome: Strategies for Long-Term Efficacy.
Review in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a common disorder of gut-brain interaction. Current therapeutic approaches frequently fail to provide sustained symptom relief. In recent years, complementary and alternative therapies-particularly traditional Chinese medicine, acupuncture, and dietary interventions-have attracted increasing attention due to their low side-effect profiles and are gradually becoming important adjunct strategies in the management of IBS-D. This review systematically summarizes the research advances of the past decade across these three therapeutic categories for IBS-D with a focus on their clinical efficacy and underlying mechanisms. The findings suggest that traditional Chinese medicine, acupuncture, and dietary interventions can provide sustained relief from core symptoms of IBS-D, including diarrhea and abdominal pain. Their therapeutic effects are mediated through multiple mechanisms, including modulation of the gut microbiota and its metabolites, restoration of intestinal mucosal barrier integrity, attenuation of visceral hypersensitivity, and regulation of the gut-brain axis. These therapies exhibit multi-target and systemic effects with a low incidence of adverse events, highlighting their promising clinical potential. They offer feasible strategies for achieving long-term remission and facilitating personalized management of IBS-D.
Indexed as
Identifiers
42584763What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.